熱門資訊> 正文
Bionano第三季度收入跃升6%，超过2025年指导范围
2025-11-14 06:51
- Bionano Genomics (BNGO) is up ~6% in after-hours trading Thursday after reporting Q3 financial results that beat on revenue and reiterating full-year revenue guidance that includes the consensus.
- Full-year revenue is projected at $26M-$30M. Consensus is $28.45M. Q4 revenue, however, is not expected to include the consensus of $8.36M with a range of $7.5M-$7.9M.
- In Q3, Bionano significantly reduced its year-over-year next loss to (~$8.5M) from (~$44.2M).
- The company ended the quarter (Sept. 30) with cash, cash equivalents, and investments of ~$21.6M compared to ~$9.5M on Dec. 31, 2024.
More on Bionano Genomics
- Bionano Genomics, Inc. (BNGO) Presents At H.C. Wainwright 27th Annual Global Investment Conference Prepared Remarks Transcript
- Bionano Genomics reports Q3 results
- Bionano Genomics Q3 2025 Earnings Preview
- Seeking Alpha’s Quant Rating on Bionano Genomics
- Historical earnings data for Bionano Genomics
推薦文章
年終盤點 | 最賺錢打新榜出爐！一手最高賺1.46萬，首日狂飆超360%，2025港股打新到底有多猛？
美股機會日報 | 貴金屬史詩級牛市！黃金年內飆升70%，漲破4500美元關口；英特爾遭利空一度跌逾5%
聖誕節休市提醒：港股休市兩天半，美股休市一天半
谷歌年初在人工智能競賽中落后，卻在2025年末登頂行業榜首
華盛早報 | 美聯儲主席熱門人選哈塞特：降息節奏仍需加速！英偉達稱春節前向中國交付H200芯片；中芯國際對部分產能漲價10%
12月24日外盤頭條：美國消費者信心連續第五個月下滑 金銀連續兩日刷新歷史新高 特朗普提美聯儲主席必要條件
美聯儲主席候選人哈塞特：美國在降息方面已嚴重滯后
資金覆盤 | 北水淨買入港股6.11億港元，加倉阿里超13億港元，賣出騰訊超10億港元
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
